Physician
Mohamed Ayad, M.D., P.C.
Mohamed Ayad, M.D., P.C. was paid $6.67M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoMOHAMED AYAD, M.D., P.C.
DEARBORN, MI 48126
DEARBORN, MI 48126
33aNPI1962823005assigned 12/16/2013
33bProvider typeFamily Medicine Physician
28Total paid$6.67M
24GClaims196,098
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#16 of 826
Median peer was paid$98K
This provider vs. median68×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,743 | $791K | |
| 2019 | 25,722 | $723K | |
| 2020 | 26,141 | $755K | |
| 2021 | 36,224 | $1.11M | |
| 2022 | 34,149 | $1.17M | |
| 2023 | 26,851 | $1.19M | |
| 2024incomplete | 18,268 | $939K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 34,394 | 30,727 | $3.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 24,320 | 21,934 | $1.61M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.7% | 4,599 | 4,586 | $447K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.7% | 3,513 | 3,503 | $311K |
| 99442 | 1.4% | 1,562 | 1,493 | $96K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 7,093 | 6,995 | $88K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.3% | 1,037 | 1,030 | $86K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,052 | 1,925 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,771 | 9,645 | $60K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,406 | 6,017 | $57K |
| 80053 | Comprehensive metabolic panel | <1% | 6,890 | 6,798 | $57K |
| 82607 | <1% | 5,760 | 5,679 | $55K |
69 more codes
| 82728 | <1% | 5,715 | $51K | |
| 84439 | <1% | 7,190 | $50K | |
| 80061 | Lipid panel | <1% | 5,009 | $48K |
| 82746 | <1% | 5,021 | $46K | |
| 99385 | <1% | 415 | $44K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,318 | $35K |
| 99441 | <1% | 948 | $32K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,770 | $30K |
| 99454 | <1% | 883 | $27K | |
| 90674 | <1% | 1,100 | $25K | |
| 99457 | <1% | 882 | $24K | |
| 83735 | <1% | 4,430 | $22K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,205 | $21K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,660 | $17K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,876 | $17K |
| 99406 | <1% | 2,560 | $16K | |
| 93000 | <1% | 1,948 | $16K | |
| 72100 | <1% | 755 | $16K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 177 | $16K |
| 96127 | <1% | 4,650 | $14K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,350 | $13K |
| 82948 | <1% | 4,754 | $12K | |
| 87428 | <1% | 286 | $11K | |
| 81003 | <1% | 5,654 | $10K | |
| 99401 | <1% | 2,214 | $9K | |
| 81025 | <1% | 1,258 | $8K | |
| 82947 | <1% | 3,079 | $8K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 25 | $7K |
| 80305 | <1% | 795 | $6K | |
| 90686 | <1% | 355 | $6K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 251 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,868 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 115 | $4K |
| 81002 | <1% | 1,827 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,527 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 268 | $3K |
| 20552 | <1% | 141 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,084 | $3K |
| 99386 | <1% | 24 | $3K | |
| 90656 | <1% | 192 | $3K | |
| 99453 | <1% | 247 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 39 | $2K |
| 73560 | <1% | 92 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $2K |
| 74022 | <1% | 44 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 213 | $1K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 148 | $743.61 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 672 | $704.31 |
| 86580 | <1% | 127 | $694.72 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 31 | $439.46 |
| 82044 | <1% | 85 | $371.84 | |
| 71045 | Radiologic examination, chest; single view | <1% | 24 | $321.42 |
| 83014 | <1% | 79 | $260.32 | |
| 82570 | <1% | 86 | $239.64 | |
| 72040 | <1% | 12 | $235.32 | |
| 74018 | <1% | 13 | $230.87 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 50 | $167.67 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 88 | $146.61 |
| G0008 | Administration of influenza virus vaccine | <1% | 81 | $16.13 |
| 1170F | <1% | 383 | $0.16 | |
| 3044F | <1% | 125 | $0.02 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 432 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 307 | $0.00 |
| 87581 | 0% | 13 | $0.00 | |
| 99000 | 0% | 77 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 102 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 475 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 48 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAYAD, MOHAMED (PHYSICIAN)